Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7446 p390
7 April 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Project seeks to improve safety of injectables

Safety issues affecting injectable medicines are to be tackled through a project established by the NHS Purchasing and Supply Agency.

The pilot project is a collaboration with the pharmaceutical industry and will operate across a number of NHS sites.

Tom Gray, chief pharmacist at Derby Hospitals NHS Foundation Trust, one of the trusts involved in the project, told The Journal: “[The project] is an exciting opportunity to understand better the risks of intravenous medicines therapy and improve our products and service to patients in this trust, as well as contribute to safer and more cost-effective solutions across the NHS, and build on our existing expertise in this area.”

Last week, the National Patient Safety Agency recommended that health care staff should implement a “purchasing for safety” policy for injectable medicines. The advice came as part of the NPSA’s work programme (PJ, 31 March, p356), which is the focus of a News feature this week (p392).

Two free-of-charge training days to support implementation of the NPSA’s alert on injectable medicines have been organised by Baxter Healthcare. The events are aimed at chief pharmacists and others involved in implementing the alert. They will take place in London on 13 June and in Harrogate on 25 June 2007.

Details are available by e-mailing patient_safety_uk@baxter.com

Back to Top


©The Pharmaceutical Journal